Be Clinical raises Rs 21 Cr led by Sauce for clinical skincare

Be Clinical has raised Rs 21 Cr, about $2.2 Mn, in a round led by Sauce, Inc42 reported on 22 August 2026. Existing investor V3 Ventures took part, along with angels including Mokobara founders Sangeet Agrawal and Navin Parwal, Reckitt SVP Arjun Purkayastha, and Shaunak Chirayu Amin.

The brand sells clinically tested skincare aimed at ageing. Products include PlumpX Serum, FirmX Serum, Revive 10 Eye Cream and Neck Repair Cream. It sells through its own D2C website and on Amazon and Flipkart. Founder Hemangi Dhir launched the brand in 2025, after two years of research and development.

Be Clinical reports 1.2 lakh orders since launch and describes its repeat rates as healthy. That is the company’s own characterisation, with no number attached, so there is nothing to benchmark it against yet.

Claims are an operating cost in this category

Look at the product names. PlumpX, FirmX, Revive 10, Neck Repair. Each one is a claim wearing a product name. Anti ageing skincare in India is a claims heavy category, which means substantiation files and claim wording belong inside operations, not at the end of a legal review after the copy is written.

In practice that is three habits. Every active claim needs a study or test report on file before listing copy goes live. The marketplace listing, the D2C page, the pack and the creator brief must say the same thing in the same words, because a mismatch is what a complaint hangs on. And someone owns the file when a marketplace asks, with a working turnaround time. Marketplaces pull listings on claim complaints, and a suppressed hero SKU during a sale window costs far more than the paperwork would have. If you run a similar catalogue, audit claim wording across all three channels before the festive push.